These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3678161)

  • 1. A randomised, prospective study comparing two contrast media in ERCP.
    Cunliffe WJ; Cobden I; Lavelle MI; Lendrum R; Tait NP; Venables CW
    Endoscopy; 1987 Sep; 19(5):201-2. PubMed ID: 3678161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iopamidol as contrast medium in endoscopic retrograde pancreatography: a prospective randomised comparison with diatrizoate.
    O'Connor HJ; Ellis WR; Manning AP; Lintott DJ; McMahon MJ; Axon AT
    Endoscopy; 1988 Sep; 20(5):244-7. PubMed ID: 3168937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of contrast agents for endoscopic retrograde pancreatography.
    Barkin JS; Casal GL; Reiner DK; Goldberg RI; Phillips RS; Kaplan S
    Am J Gastroenterol; 1991 Oct; 86(10):1437-41. PubMed ID: 1928034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trial of low versus high osmolar contrast media in endoscopic retrograde cholangiopancreatography.
    Banerjee AK; Grainger SL; Thompson RP
    Br J Clin Pract; 1990 Nov; 44(11):445-7. PubMed ID: 2282293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of pain and heat sensation of contrast media in aortofemoral angiography: meglumine-amidotrizoate (Angiografin) mixed with lidocaine versus sodium-meglumine-ioxaglate (Hexabrix).
    Heystraten FM; van den Berg FG; Mulderije ED
    Diagn Imaging; 1983; 52(2-3):141-4. PubMed ID: 6851813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metrizamide as contrast medium in endoscopic retrograde cholangio-pancreatography.
    Hamilton I; Lintott DJ; Rothwell J; Axon AT
    Clin Radiol; 1982 May; 33(3):293-5. PubMed ID: 7042178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental pancreatography: a comparison of three contrast media.
    Saari A; Kivisaari L; Standertskjöld-Nordenstam CG; Brackett K; Schröder T
    Scand J Gastroenterol; 1988 Jan; 23(1):53-8. PubMed ID: 3344398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The frequency of hyperamylasemia after ERCP with diatrizoate and iohexol.
    Mäkelä P; Dean PB
    Eur J Radiol; 1986 Nov; 6(4):303-4. PubMed ID: 2431908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The dose-response relationship in the use of hexabrix in angiography].
    Tatochenko KV; Kondrashin SA
    Vestn Rentgenol Radiol; 1991; (5):18-20. PubMed ID: 1799037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A life-threatening contrast-medium reaction during ERCP].
    Zimmerer J; Mainos D; Tittor W; Spannagel B
    Dtsch Med Wochenschr; 1990 Jul; 115(27):1077-8. PubMed ID: 2364886
    [No Abstract]   [Full Text] [Related]  

  • 11. Different contrast agents and development of pancreatitis after endoscopic retrograde pancreatography.
    Short TP; Thomas E
    Am J Gastroenterol; 1992 May; 87(5):682-3; author reply 684-5. PubMed ID: 1595669
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative study of two iodinated contrast media containing 20% iodine in lower-limb phlebography: ioxaglate versus a conventional product.
    Trigaux JP; de Fays R; de Fays F
    Br J Radiol; 1985 Mar; 58(687):203-5. PubMed ID: 3904894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pain during angiography: a randomized double-blind trial comparing ioxaglate and diatrizoate.
    Pathria M; Somers S; Gill G
    Can Assoc Radiol J; 1987 Mar; 38(1):32-4. PubMed ID: 2953734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different contrast agents and development of pancreatitis after endoscopic retrograde pancreatography.
    Banerjee A
    Am J Gastroenterol; 1992 May; 87(5):683-4; author reply 684-5. PubMed ID: 1595671
    [No Abstract]   [Full Text] [Related]  

  • 15. High-dose clinical urography with the low-osmolality contrast agent Hexabrix: comparison with a conventional contrast agent.
    Spataro RF; Katzberg RW; Fischer HW; McMannis MJ
    Radiology; 1987 Jan; 162(1 Pt 1):9-14. PubMed ID: 3538156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iopentol (Imagopaque 250) compared with diatrizoate (Urografin 219) in endoscopic retrograde cholangio-pancreatography (ERCP). A clinical trial assessing safety (adverse events and S-pancreatic iso-amylase) and diagnostic information (VAS).
    Kruse A; Brock A; Rodenberg J; Nowakowska-Duawa E; Bjartveit K
    Eur Radiol; 1997; 7 Suppl 4():S131-4. PubMed ID: 9204355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective randomized double-blind placebo-controlled trial of glyceryl trinitrate in endoscopic retrograde cholangiopancreatography-induced pancreatitis.
    Sudhindran S; Bromwich E; Edwards PR
    Br J Surg; 2001 Sep; 88(9):1178-82. PubMed ID: 11531863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous digital subtraction angiography with iohexol (Omnipaque) and sodium meglumin diatrizoate (Urografin).
    Karle A; Fries J; Laulund S; Andrew E
    Diagn Imaging Clin Med; 1986; 55(6):352-9. PubMed ID: 3545629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary arteriography: comparison of cough stimulation effects of diatrizoate and ioxaglate.
    Smith DC; Lois JF; Gomes AS; Maloney MD; Yahiku PY
    Radiology; 1987 Mar; 162(3):617-8. PubMed ID: 3544028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombosis following phlebography with high-osmolar and low-osmolar contrast media.
    Eliasen B; Hørup A; Jensen AR
    Eur J Radiol; 1983 May; 3(2):97-8. PubMed ID: 6347689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.